FDA Gives Final Approval to Abuse-Deterrent Xtampza ERFDA Gives Final Approval to Abuse-Deterrent Xtampza ER

The approval of the abuse-deterrent oxycodone formulation follows 'tentative' approval last fall for management of chronic pain requiring daily, around-the-clock opioid treatment. FDA Approvals
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Neurology & Neurosurgery News Alert Source Type: news